|
|
||||||||
Ann Thorac Surg 1993;56:68-73
© 1993 The Society of Thoracic Surgeons
Bordeaux Lung and Heart-Lung Transplant Group, Pessac, France
* Address reprint requests to Dr Dromer, Service de Chirurgie Thoracique, Höpital Xavier Arnozan, 33604 Pessac Cedex, France.
Between February 1988 and January 1992, 61 patients have undergone bilateral lung transplantations (42 heart-lung and 19 double-lung) in Bordeaux. The underlying diseases were primary or secondary hypertension (20), emphysema (22), or other diseases including cystic fibrosis, pulmonary fibrosis, silicosis, and sarcoidosis (19). Actuarial survival for double-lung and heart-lung transplant recipients was 66% and 72% at 1 year and 57% and 53% at 3 years, respectively. Forty-two patients were still alive 6 months after operation, and we studied their pulmonary function at the short and long term. All parameters except arterial carbon dioxide tension had improved dramaticaly at 6 months (p < 0.0001). Vital capacity, forced expiratory volume in 1 second, and forced expiratory flow rate between 25% and 75% of vital capacity were at 79% ± 3%, 92% ± 5%, and 105% ± 8% of the predicted values, respectively. Arterial oxygen tension was 88 ± 3 mm Hg. Nine months after operation, a slight decrease in forced expiratory volume in 1 second and forced expiratory flow rate between 25% and 75% of vital capacity appeared but values remained more than 75% predicted. This was related to the occurrence of obliterative bronchiolitis in 6 patients (14%). At 9 months, flow rates and oxygen tension of these 6 patients were highly different from those of patients free of obliterative bronchiolitis (p < 0.0002 for flow rates and p < 0.01 for oxygen tension). Only 1 patient required retransplantation. The others are living an almost normal life. Our results are discussed in view of the published reports on single-lung transplantation. Short-term results of bilateral lung transplantation are thus excellent and maintained on a long-term basis. Therefore, in our opinion, bilateral lung transplantation is the therapy of choice for pulmonary hypertension and emphysema.
This article has been cited by other articles:
![]() |
E. N. Mendeloff, C. B. Huddleston, G. B. Mallory, E. P. Trulock, A. H. Cohen, S. C. Sweet, J. Lynch, S. Sundaresan, J. D. Cooper, and G. A. Patterson Pediatric And Adult Lung Transplantation For Cystic Fibrosis J. Thorac. Cardiovasc. Surg., February 1, 1998; 115(2): 404 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Bavaria, R. Kotloff, H. Palevsky, B. Rosengard, J. R. Roberts, P. M. Wahl, N. Blumenthal, C. Archer, and L. R. Kaiser BILATERAL VERSUS SINGLE LUNG TRANSPLANTATION FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE J. Thorac. Cardiovasc. Surg., March 1, 1997; 113(3): 520 - 528. [Abstract] [Full Text] |
||||
![]() |
E. M. Baudet, C. Dromer, J. Dubrez, J. B. Jougon, X. Roques, J.-F. Velly, C. Deville, L. Couraud, and T. B. L. a. H.-L. T. Group INTERMEDIATE-TERM RESULTS AFTER EN BLOC DOUBLE-LUNG TRANSPLANTATION WITH BRONCHIAL ARTERIAL REVASCULARIZATION J. Thorac. Cardiovasc. Surg., November 1, 1996; 112(5): 1292 - 1300. [Abstract] [Full Text] |
||||
![]() |
H. Reichenspurner, R. E. Girgis, R. C. Robbins, J. V. Conte, R. V. Nair, V. Valentine, G. J. Berry, R. E. Morris, J. Theodore, and B. A. Reitz Obliterative bronchiolitis after lung and heart-lung transplantation Ann. Thorac. Surg., December 1, 1995; 60(6): 1845 - 1853. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |